INNOCAN PHARMA Corp SEC filings INNPF
INNOCAN PHARMA Corp has 48 filings in SEC EDGAR's recent list, going back to Oct 26, 2021. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| RW | Filing | Feb 23, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| 8-A12B/A | Filing | Dec 22, 2025 | — |
| 8-A12B/A | Filing | Dec 19, 2025 | — |
| 8-A12B/A | Filing | Dec 16, 2025 | — |
| DEL AM | Filing | Nov 10, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| 8-A12B | Filing | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2025 | — |
| DRS/A | Filing | Jun 20, 2025 | — |
| DRSLTR | Filing | May 15, 2025 | — |
| DRS/A | Filing | May 15, 2025 | — |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| DRSLTR | Filing | May 12, 2025 | — |
| DRS/A | Filing | May 12, 2025 | — |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| DRSLTR | Filing | May 1, 2025 | — |
| DRS/A | Filing | May 1, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2025 | — |
| DRSLTR | Filing | Mar 28, 2025 | — |
| DRS/A | Filing | Mar 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2025 | — |
| DRS | Filing | Dec 31, 2024 | — |
| D | Filing | Oct 26, 2021 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INNPF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Calgary
- SEC CIK
- 1889791
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.